Pregnancy and neuromyelitis optica spectrum disorders: 2022 recommendations from the French Multiple Sclerosis Society - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Multiple Sclerosis Journal Année : 2023

Pregnancy and neuromyelitis optica spectrum disorders: 2022 recommendations from the French Multiple Sclerosis Society

Romain Marignier
Bertrand Bourre
  • Fonction : Auteur
Mikael Cohen
Maxime Guillaume
  • Fonction : Auteur
Clarisse Carra-Dalliere
Anne-Marie Guennoc
  • Fonction : Auteur
Géraldine Androdias
  • Fonction : Auteur
Caroline Bensa
  • Fonction : Auteur
Kevin Bigaut
Damien Biotti
Pierre Branger
  • Fonction : Auteur
Elodie Daval
  • Fonction : Auteur
Cécile Donze
  • Fonction : Auteur
Anne-Laure Dubessy
  • Fonction : Auteur
Arnaud Kwiatkowski
  • Fonction : Auteur
Cécile Dulau
  • Fonction : Auteur
Françoise Durand-Dubief
  • Fonction : Auteur
Benjamin Hebant
  • Fonction : Auteur
Julien Lannoy
  • Fonction : Auteur
Eric Manchon
  • Fonction : Auteur
Guillaume Mathey
  • Fonction : Auteur
Xavier Moisset
Alexis Montcuquet
  • Fonction : Auteur
Thomas Roux
Elisabeth Maillart

Résumé

Background: In 2020, the French Multiple Sclerosis (MS) Society (SFSEP) decided to develop a national evidence-based consensus on pregnancy in MS. As neuromyelitis optica spectrum disorders (NMOSD) shares a series of commonalities with MS, but also some significant differences, specific recommendations had to be developed.Objectives: To establish recommendations on pregnancy in women with NMOSD.Methods: The French Group for Recommendations in Multiple Sclerosis (France4MS) reviewed PubMed and universities databases (January 1975 through June 2021). The RAND/UCLA appropriateness method, which was developed to synthesise the scientific literature and expert opinions on health care topics, was used to reach a formal agreement. Fifty-six MS experts worked on the full-text review and initial wording of recommendations. A sub-group of nine NMOSD experts was dedicated to analysing available data on NMOSD. A group of 62 multidisciplinary healthcare specialists validated the final proposal of summarised evidence.Results: A strong agreement was reached for all 66 proposed recommendations. They cover diverse topics, such as pregnancy planning, follow-up during pregnancy and postpartum, delivery routes, loco-regional analgesia or anaesthesia, prevention of postpartum relapses, breastfeeding, vaccinations, reproductive assistance, management of relapses, and disease-modifying treatments.Conclusion: Physicians and patients should be aware of the new and specific evidence-based recommendations of the French MS Society for pregnancy in women with NMOSD. They should help harmonise counselling and treatment practise, allowing for better individualised choices.
Fichier non déposé

Dates et versions

hal-03871563 , version 1 (25-11-2022)

Identifiants

Citer

Sandra Vukusic, Romain Marignier, Jonathan Ciron, Bertrand Bourre, Mikael Cohen, et al.. Pregnancy and neuromyelitis optica spectrum disorders: 2022 recommendations from the French Multiple Sclerosis Society. Multiple Sclerosis Journal, 2023, 29 (1), pp.37-51. ⟨10.1177/13524585221130934⟩. ⟨hal-03871563⟩
1144 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More